Remove Clinical Supply Remove DNA Remove Magazine
article thumbnail

Rapid delivery of toxicological material

Drug Target Review

To achieve an aggressive timeline from DNA to investigational new drug (IND) application, drug developers have strengthened collaborations with contract development & manufacturing organisations (CDMOs) to expedite drug development. Network Pharma Magazine. 2023 Jan-Dec;15(1):2220150. 4 Berrie J, Donninger R.